灵康药业：关于不向下修正“灵康转债”转股价格的公告

Core Viewpoint - Lingkang Pharmaceutical announced that its stock price has fallen below 85% of the current conversion price for at least 15 trading days within a consecutive 30-day period, triggering the downward adjustment clause for its convertible bonds [2] Group 1: Company Actions - The company's board of directors has decided not to exercise the right to adjust the conversion price of the "Lingkang Convertible Bonds" downward at this time [2] - The company will not propose a downward adjustment plan if the conditions for the conversion price adjustment are triggered again within the next month, from December 10, 2025, to January 9, 2026 [2] - Starting from January 12, 2026, if the conditions for the downward adjustment are triggered again, the board will convene to review whether to exercise the right to adjust the conversion price [2]